Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.32) by 12.9 percent. This is a 8 percent decrease over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $401.000 thousand which beat the analyst consensus estimate of $400.000 thousand by 0.25 percent.